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ABSTRACT
When using fX714 RF DNA as a template, in vitro, E. coli RNA polymerase
synthesizes four major purine triphosphate-containing 5' end sequences. RNase
A digests of a32P labeled ]RNA were further digested with spleen exonuclease
to remove the bulk of the oligonucleotides with 5' hydroxyls and then chro-
matographed on DEAE cellulose to resolve the remaining 5' terminal oligonu-
cleotides. By application of standard separation and sequence techniques,
the major 5' end sequences were shown to be: pppApUp(Cp), pppApApApUp(Cp),
pppApApApApUp(Cp), and pppGpApUp(Gp)..
INTRODUCTION
Bacteriophage fX7l4 stimulates the synthesis of a number of mRNAs of
discrete sizes during infection of E. colil'2. Hayashi et al.3 have pre-
sented evidence that mRNAs with similar molecular weights to some of the in
vivo *X mENAs are synthesized in vitro in the presence of rho factor4.
Though no evidence has appeared to show what part E. coli RNase III5 plays
in the production of any of the OX mRNAs found in vivo, RNase III does appear
to be responsible for the generation of most, if not all, of the T7 early
mBNA species observed in vivo from longer precursors arising from three
closely spaced initiations7. OX mRNA as well seems to be initiated from more
than one promotor since (1) Hayashi and Hayashi8 have reported that both y32p
ATP and y32P GTP are incorporated into OX mRNA produced in vitro and (2) Chen
et al.9 have shown that three of the discrete fragments of OX RF DNA produced
by HindII+,,, endonuclease cleavage contain E. coli RNA polymerase binding
sites. The present report confirms the existence of more than one 5' end
nucleotide sequence in in vitro OX mRNA, and describes a procedure for the
isolation and characterization of the 5' oligonucleotides derived from a32p
ribonucleoside triphosphate-labeled in vitro OX mRNA.
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MATERIALS AND METHODS
(1) Preparation of 0X174 RFI: RFI is isolated by the procedure of
Komano and Sinsheimer10 through the phenol extraction and first isopropanol
precipitation steps. Subsequently, the precipitate is redissolved then
treated with RNase A (2 ug/OD260 unit),37TC72 hr, extracted with phenol five
times, and precipitated with isopropanol two times. The resulting precipitate is
redissolved in 0.05 M Tris-Cl pH 7.9, 0.005 M EDTA and further purified by
gel filtration on Biogel A 1.5 m (Biorad) as described by Komano and
Sinsheimer9 or on a porous glass bead column (Corning CPG 2000 Biorad) in
Tris-EDTA buffer. The DNA excluded from these coluimns is already 95-98% OX
RFI + II as judged by analytical sedimentation through 3 M CsCl + 0.1 N KOH
in a Beckman Model E ultracentrifuge. RFI is purified to homogeneity by CsCl
equilibrium banding in the presence of 500 ig/ml propidium diiodidell. RFI
is separated from propidium diiodide by passage through Dowex AG50W-X2 (Biorad)
in 0.5 M Tris-Cl pH 7.9, 0.005 M EDTA, followed by dialysis versus 0.05 M
Tris-Cl pH 7.9, 0.005 M EDTA. The resulting RFI preparations sometimes con-
tain traces (0-1%) of RFII.
(2) E. coli K12 RNA polymerase: RNA polymerase is purified accordin'g
to the method of Burgess and Travers12. The Agarose column fraction is used
in most of the experiments described here, although identical results are
obtained with homogeneous RNA polymerase purified by glycerol gradient sedi-
mentation.
(3) 32p ribonucleoside triphosphates: y32P ATP and y32P GTP are ob-
tained from ICN at specific activities of > 75c/mM. ac32P ribonucleoside
triphosphates are obtained from New England Nuclear Corporation at specific
activities of > lOOc/mM.
(14) Preparation of 32P-labeled, in vitro, OX mRNA: y or a32P ribonu-
cleoside triphosphates are evaporated to dryness and redissolved in the
standard reaction mixture of 200 jil which contains 0.05 M Tris-Cl pH 7.9,
0.2 M KC1, 0.01 M MgCl2, 0.1 mM EDTA, 0.1 mM dithiothreitol, 100 pg OX RFI32
and 500 jg RNA polymerase (holoenzyme). P-labeled triphosphates are pre-
sent at 0.1 to 0.2 mM, unlabeled triphosphates at 0.5 mM. a32P labeling
reactions are allowed to proceed for one minute at 370C after the addition
of RNA polymerase, then terminated by immersion in a boiling water bath for
one minute. After equilibration to 250C, DNase I (RNase free, Worthington)
is added to 50 pg/ml and incubated at 370C for 30 minutes. SDS is then
added to 0.2% and the mixture extracted with phenol. y32p labeling reactions
are terminated by the addition of DNase I after 30 minutes at 370C and
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allowed to incubate an additional 30 minutes at 370C. SDS and phenol are
added as above. After phenol extraction, the aqueous layers are applied
immediately to a 0.7 x 30 cm column of Sephadex G50 (fine) in 0.05 M Tris-Cl
pH 7.9, 0.005 M EDTA. Excluded RNA is pooled, its OD260mv measured, and
precipitated (0.1 volume 3 M sodium acetate pH 5, 2 volumes 100% ethanol are
added followed by incubation at -20°C for 24-8 hr before sedimentation at
20,000 rpm in Beckman SW 50.1 rotor). The RNA is redissolved in water. The
size of the RNA product from the a32P labeling reactions is heterogeneous
(data not shown), ranging from 500-2,000 nucleotides long as judged by sedi-
mentation through dimethylsulfoxide13.
(5) Digestion of the RNA with enzymes: Aliquots of the 32p labeled
RNAs are digested in 0.01 M Tris-Cl pH 7.9, 0.01 M EDTA with pancreatic RNase
A (Sigma type III-A) using an enzyme to substrate ratio of 1:15 (ig/ig);
incubation at 370C for 40 minutes gives complete digestion.
For isolation of 5' oligonucleotides from a32p labeled RNA, aliquots of
RNA are first digested in a small volume (1-2 il) with RNase A as above, then
further digested by addition of 50-100 il of bovine spleen exonuclease
(purified as per Hilmoe14, obtained from Worthington as spleen phosphodies-
terase) in 0.025 M potassium phosphate pH 6.3, 0.0025 M EDTA and incubation
for 1 hr at 370C. 3 to 5 units spleen exonuclease is added per pg RNA. SDS
is then added to 1% followed by extraction with phenol. The aqueous layer
is diluted with water to 2 ml and applied to a 0.5 x 1 cm column of Whatman
DE52. The column is washed with 0.1 M triethylammonium bicarbonate (TEAB)
pH 10 to remove nucleoside monophosphates; the remaining oligonucleotides
are eluted with 2 M TEAB pH 10. The TEAB is removed by repeated evaporation
with equal volumes of methanol and finally once with 2 ml water. The nucle-
otides are redissolved in 1-2 pl 0.005 M EDTA and directly applied to
cellulose acetate strips for ionophoresis as described by Barrell15. Homo-
chromatography (using the 30 minute homomixture) is performed on DEAE
cellulose-coated polyethylene sheets (Polygram cel 300 DEAE, Brinkran Inst.).
Spots from homochromatography are cut out and counted for Cerenkoff radio-
activity in 12 ml 100% ethanol, then scraped off into a suction device16,
washed with additional ethanol, and eluted with 0.25 M NH4OH.
The eluted oligonucleotides are evaporated to dryness, redissolved in
10 pl 0.02 M EDTA, and then digested to mononucleotides by adding 1 pl of an
RNase mixture (100 units/ml T2 RNase [Sigma], 10 units/ml p2 RNase [Calbio-
chem], 2.5 mg/ml RNase A [Sigma], and 5,000 P/ml T RNase [Calbiochem] in1
0.5 M ammonium acetate pH 14.5). The oligonucleotides are digested for 5 hr
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at 37°C. The enzymatic degradation of these oligonucleotides is more rapid
than alkaline hydrolysis, and seems to result in less destruction of the
purine tetraphosphates.
The digests are examined for nucleotide composition by streaking half
on Whatman DE81 paper and half on Whatman 540 paper. Ionophoresis is per-
formed in the pH 3.5 (no urea) buffer of Barrell15. The DEAE ionophoresis
allows identification of pppAp and pppGp; the 540 system resolves the four
nucleoside 3' monophosphates.
RESULTS
(1) Characterization of y32p ATP and y32P GTP 5' oligonucleotides. In
vitro OX mRNAs labeled at the 5' end with either Y32P ATP or y32P GTP are
digested and separated as described above. RNase A digests of y32p ATP
labeled RNA (Figure la) show three major 5' end oligonucleotides comprising
95% of all radioactivity on the chromatogram. Figure lb is the pattern ob-
tained from RNase A digests of y32P GTP labeled RNA; the major spot accounts
for s75% of the radioactivity, while the remainder is distributed among
several minor oligonucleotides. During the course of this work, we have
noticed that these minor y32P GTP-labeled oligonucleotides, as well as a few
minor 'y32P ATP-labeled oligonucleotides are present in much higher yields
(sometimes amounting to 30-50% of all radioactivity) when the RNA is synthe-
sized by RNA polymerase which has been stored (-200C 50% glycerol storage
buffer) for longer than three or four months. In the present study, freshly
prepared RNA polymerase (< two months old) has been used exclusively. Con-
sequently, the minor spots have appeared in very low yields and no attempt
was made to determine their sequence.
The positions of the RNase A y32p ATP and y32P GTP-labeled oligonucle-
otides, relative to each other, can be seen from Figure lc. The major y32P
GTP-labeled spot migrates in the homochromatography dimension as if it were
one nucleotide larger than the uppermost y32P ATP-labeled spot. If the
y32P ATP-labeled RNA is digested with a mixture of RNase A and T1, three
spots of identical mobilities to the spots in Figure la are seen (data not
shown), indicating the absence of guanosine residues between the 5' pppAp
and the pyrimidine at the 3' end.
(2) Digestion with spleen exonuclease. The RNase A digests of a32P-
labeled RNAs contain many nucleotides which obscure the positions of the 5'
oligonucleotides on the homochromatograms (data not shown). Bovine spleen
exonuclease13 is employed to digest to mononucleotides any oligonucleotides
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Figure 1. Autoradiograms. RNase A digests of y32P-labeled in vitro *X mRNA.
First dimension ionophoresis is from left to right; homochromatography is
from bottom to top. Dotted circle marks position of yellow marker dye. (a)
y32p ATP-labeled RNA, (b) y32P GTP-labeled RNA, (c) a mixture of y32p ATP-
and y32p GTP-labeled RNAs.
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Figure 2. Autoradiograms. Spleen exonuclease treated RNase A digests of
a P-labeled in vitro fX mRNA. (a) A mixture of in vitro fX mRNAs labeled
independently with each a32P ribonucleoside triphosphate, (b) a32P ATP-label-
ed RNA, (c) a32P GTP-labeled RNA.
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Figure 2. (continued) (d) a32P UTP-labeled RNA, (e) a32p CTP labeled RNA.
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containing a 5' hydroxyl; 5' phosphorylated oligonucleotides are resistant
to such digestion17.
The commercially available spleen phosphodiesterase (spleen exonuclease)
is, however, contaminated with variable amounts of spleen acid ribonuclease
and phosphatase18. Batches of spleen exonuclease are assayed for phosphatase
contamination by digesting aliquots of RNase A digested a32P-labeled RNAs
with varying amounts of exonuclease. The digests are separated by one dimen-
sional ionophoresis on DEAE paper and autoradiographed. The presence of
phosphatase is indicated by the appearance of inorganic 32po . Ribonuclease
activity is assayed by digesting aliquots of y32P-labeled RNiA with spleen
exonuclease and separating the digestion products as above. The presence of
RNase is indicated by the appearance of pppAp. If the contaminating ribo-
nuclease and/or phosphatase activities are unacceptably high, the exonuclease
activity can be purified by Sephadex G75 filtration (removes RNase) and
Sephadex C50 chrcmatography (removes phosphatase) by the methods of Bernardi
and Bernardi18. The purified preparations are free of detectable Riase and
phosphatase activities, but some loss in exonuclease activity is observed.
Results similar to those reported here are obtained with highly purified
preparations, although the present data were derived using an uncontaminated
commercial batch.
After digestion with spleen exonuclease, followed by SDS-phenol
extraction, the DEAE step removes >95, of the total radioactivity and in
addition removes salt which would cause extensive streaking of the nucleo-
tides during ionophoresis.
(3) Isolation and sequence of RNase A a32P-labeled 5' purine tri-
phosphate-containing oligonucleotides. Figures 2a-e are autoradiograms of
the spleen exonuclease treated RNase A oa32P-labeled oligonucleotides after
homochromatography. From 2a to e these correspond to RNA labeled with
(a) all four a32P ribonucleoside triphosphates, combined after synthesis,
(b) a32P ATP, (c) a32P GTP, (d) a32P UTP, (e) a32p CTP. Comparison of
these figures to Figures la-c enables identification of the three major
5' pppA oligonucleotides and the major 5' pppG oligonucleotide. These
four spots have been termed 1-4 from top to bottom. a32 P CTP does not
label spot 2 and a32p GTP does not label spots 1, 3, or 4. a32p CTP and
a32P GTP label a spot (marked by an arrow) which seems to contain a single
nucleotide (it is not cleaved by T2 or alkaline digestion). This spot is
neither pppAp or pppGp, nor does it seem to be di- or triphosphorylated
adenosine or quanosine. Its identity is being examined and will be discussed
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elsewhere.
Other oligonucleotide spots -can be seen in Figures 2a-e which have no
relation to the mobilities of the major y32p labeled spots of Figures la-c.
Nucleotide composition analysis of the spots from Figure 2 (data not shown)
reveals that the spots marked 1-4 are the only purine triphosphate containing
nucleotides present; these have closely matching mobilities to the y32p
labeled spots of Figure lc and are considered to be identical. The oligo-
nucleotides which do not contain purine-triphosphates, appear in variable
amounts from digest to digest. These are, as would be expected with the use
of pancreatic ribonuclease, purine-rich; some of these contain 5' di- or
monophosphates which may arise from loss of 5' terminal y or $ phosphates or
from internal chain damages (perhaps due to radiation damage). Nucleotides
arising from chain breakage after disintegration of 32p to 32S may still
contain\5' sulfate groups capable of inhibiting attack by spleen exonuclease.
However, many of the residual oligonucleotides which do not contain purine-
triphosphates yield only 3' monophosphates upon T2 digestion. It is not
known whether these fragments are present because of some feature of their
sequence which confers spleen exonuclease resistance, or whether under the
conditions described here digestion with spleen exonuclease may be incom-
plete. These fragments, however, have not interfered with the characteri-
zation of the four specific oligonucleotides which contain purine-triphos-
phate. The radioactivity occasionally present- at the transfer origin
appears in variable amounts and is of unknown composition; it was not ana-
lyzed further.
The nucleotide compositions of the RNase A a32P-labeled oligonucleo-
tides from Figures 2a-e are given in Table 1. The nearest neighbor informa-
tion gained from analysis of each oligonucleotide labeled with each of the
a32P ribonucleoside triphosphates separately, together with the known spec-
ificity of RNase A for pyrimidines, is sufficient to deduce the sequence of
these oligonucleotides. The identity of the nucleotide responsible for the
3' phosphate is also deduced; though not present in the oligonucleotide, the
3' phosphate donor is shown in parenthesis. The sequences derived are con-
sistent with the nucleotide compositions of the 5' oligonucleotides labeled
with a combination of all four 32p ribonucleoside triphosphates (combined
after synthesis). Spots 3 and 4 contain different numbers of Ap residues.
From the ratios of radioactivity in pppAp and Ap after DEAE ionophoresis of
RNase T2T1p2A digests of spots 3 and 4, the sequences pppAp(Ap)2Up(Cp) and
pppAp(Ap) 3Up(Cp) are deduced.
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TABLE 1. Nucleotide Compositions of RNase A 5' Oligonucleotides
Spot Label ~~~CompositionSpot (relative yield) Sequence
ATP pppAp
GTP ---
1 UTP pppAp pppApUp(Cp)
CTP UP
XTP pppAp,Up
ATP pppGp
GTP pppGp,Up (1.1:1) pppGpApUp(Gp)
2 UTP Ap
CTP ---
XTP pppGp,Ap,Up
ATP pppAp,Ap (2.0:1) pppAp(Ap )2Up(Cp)
GTP
3 UTP Ap
CTP Up
XTP pppAp,Ap,Up
ATP pppAp,Ap (1.1:1)
GTP
4 UTP Ap pppAp(Ap) 3Up(Cp)
CTP Up
XTP pppAp,Ap,Up
TABLE 2. Relative Yields of 5' Purine Triphosphate-Containing Oligonucleo-
tides
Sequence Average Relative Yield
pppApUp(Cp) 11.3 ± 0.2
pppAp(Ap)3Up(Cp) 3.2 ± 0.3
pppGpApUp(Gp) 1.2 ± 0.1
pppAp(Ap)2Up(Cp) 1.0 ± 0.3
Average of determinations from a32P ATP and a32P UTP labeled spots. Cor-
rections made for multiple phosphates contributed by a32p ATP in spots 3
and 4.
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DISCUSSION
We have determined the sequences of the four major 5' purine triphos-
phate-containing oligonucleotides initiated in vitro by E. coli RNA polymer-
ase using fX174 RFI as a template. The relative yield of each of these 5'
oligonucleotides from 1 minute a32P labeling reactions is shown in Table 2.
pppApUp(Cp) is by far the most common sequence initiated.
RNase T1 digestion of y32P ATP-labeled RNA also generates three major
oligonucleotides (data not shown). These appear to be related to the three
major y32P ATP-labeled RNase A digestion products but are two or more nucle-
otides longer. Thus, no divergence into multiple sequences is observed for
the pppApUp(Cp) initiation at least to the length of four or five nucleo-
tides. This data and hybridization data (Smith and Sinsheimer, in prepara-
tion) suggest that the pppApUp(Cp) oligonucleotide arises from initiation at
a single site on the fX genome.
It is an obvious possibility that all three pppAp oligonucleotides are
due to initiation at a common promotor; RNA polymerase might begin tran-
scription variably within a tract of T residues. Why the polymerase would
initiate RNAs with one, three, and four adenosines at the 5' end, and none
with two adenosines, from the same promotor, however, cannot be explained at
this time. Alternatively, Chen et al. observed that three of the 4X RF
cleavage products produced by the Haemophilus restriction enzyme HindII+III
(R2,4,6.3) contain RNA polymerase binding sites; therefore, all of the
pppAp ends may not arise from a single location.
The 5' end sequences present in in vitro fX mRNA are not the same as
those determined for fd19, another small single stranded DNA containing E.
coli bacteriophage which start mainly with pppApUpG and pppGpUp. pppGpApUp
has, however, been determined as a major starting sequence for * 8020. T7
early mRNA synthesized in vivo21 and in vitro6 begins with the similar
sequence pppApUpCpGp. pppApUpCpApGp is a starting sequence found in in
vitro mRNA directed by X DNA, as are the sequences pppApUpGp, pppApCpGp,
and pppGpUpUp22.
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